Research Methodology – Antibody Drug Conjugates Market
At Straits Research, we adopt a rigorous 360° research approach that integrates both primary and secondary research methodologies. This ensures accuracy, reliability, and actionable insights for stakeholders. Our methodology for the Antibody Drug Conjugates Market comprises the following key stages:
Market Indicator & Macro-Factor Analysis
Our baseline thesis for the Antibody Drug Conjugates Market is developed by integrating key market indicators and macroeconomic variables. These include:
Factors considered while calculating market size and share
- Prevalence and incidence of diseases targeted by Antibody Drug Conjugates (ADCs).
- Number of ADCs approved and their respective sales.
- Investments in research and development of ADCs.
- Pricing trends of ADCs in different geographic markets.
- Healthcare policies and insurance cover for ADC therapies in various regions.
- Market competition - number of players and their respective market shares.
- Pipeline of upcoming ADCs and their potential market impact.
Key Market Indicators
- Number of ADCs being approved by regulatory authorities like FDA, EMA.
- Growth rate of therapy areas treated by ADCs (like cancer).
- Investment in research and development by pharmaceutical and biotech companies.
- Patent application trends in the field of ADCs.
- Manufacturing capacity for ADCs.
- Demographic trends (population increase, ageing etc.) linked to diseases targeted by ADCs.
Growth Trends
- Increasing adoption of targeted therapeutics like ADCs in clinical practice.
- Innovation in drug delivery technologies, Linker technologies and novel payload molecules.
- Growth in investments in precision medicine and personalized treatment modalities.
- Increasing healthcare spending in emerging markets leading to growth in potential user base.
- Growing awareness and acceptance of ADCs among physicians and patients.
- Anticipated launch of pipeline ADCs over the forecast period.
Secondary Research
Our secondary research forms the foundation of market understanding and scope definition. We collect and analyze information from multiple reliable sources to map the overall ecosystem of the Antibody Drug Conjugates Market. Key inputs include:
- Annual reports, investor presentations, SEC filings
- Company press releases and product launch announcements
- Public executive interviews and earnings calls
- Strategy briefings and M&A updates
- Country-level industry associations and trade bodies
- Government dossiers, policy frameworks, and official releases
- Whitepapers, working papers, and public R&D initiatives
- Relevant Associations for the Antibody Drug Conjugates Market
- Broker reports and financial analyst coverage
- Paid databases (Hoovers, Factiva, Refinitiv, Reuters, Statista, etc.)
- Import/export trade data and tariff databases
- Sector-specific journals, magazines, and news portals
- Global macroeconomic indicators and their cascading effect on the industry
- Demand–supply outlook and value chain analysis
- Consumer behaviour, adoption rates, and commercialization trends
Primary Research
To validate and enrich our secondary findings, we conduct extensive primary research with industry stakeholders across the value chain. This ensures we capture both qualitative insights and quantitative validation. Our primary research includes:
- Key Opinion Leader (KOL) Engagements
- Structured interviews with executives, product managers, and domain experts
- Paid and barter-based interviews across manufacturers, distributors, and end-users
- Discussions with stakeholders to validate demand-supply gaps
- Group discussions on emerging technologies, regulatory shifts, and adoption barriers
- Cross-verification of market sizing and forecasts with industry insiders
- Capturing business perspectives on growth opportunities and restraints
Data Triangulation & Forecasting
The final step of our research involves data triangulation ensuring accuracy through cross-verification of:
- Demand-side analysis (consumption patterns, adoption trends, customer spending)
- Supply-side analysis (production, capacity, distribution, and market availability)
- Macroeconomic & microeconomic impact factors
- Time-series analysis
- Regression and correlation studies
- Baseline modeling
- Expert validation at each stage
Outcome
The outcome is a comprehensive and validated market model that captures:
- Market sizing (historical, current, forecast)
- Growth drivers and restraints
- Opportunity mapping and investment hotspots
- Competitive positioning and strategic insights
Available for purchase with detailed segment data, forecasts, and regional insights.
Get This ReportOur Clients:
